Mycophenolate Mofetil

2 Drugs classified under this active ingredient

Immunosuppressant. Mycophenolate Mofetil 250 mg, 500 mg.
CAPS: 100 x 250 mg.
F.C. TABS: 50 x 500 mg. Dosage must me
adjust. individ. accord. to indication and pt medic. condit. See lit.
Concom. use with cyclosporine and
corticosteroids for proph. of organ reject.
in pts. receiv. allogen. ren., card. and
hepat. transplants.
C/I: Hypersensitivity to mycophenolate
mofetil /mycophenolic acid. Lact.
WOCBP who are not using highly
effective contracept. Mycophenolate
mofetil tmt. should not be init. in
WOCBP without providing a preg. test
result to rule out unintended use in
preg. Mycophenolate mofetil should not
be used during preg. unless there is no
suitable alternative tmt. to prevent
transplant rejection.

Immunosuppressant. Mycophenolate Mofetil 500 mg.
TABS: 10, 30, 50, 60. Tmt to be initiated
and maintain. by appropriat. qualified
transplant specialists. Ren. transplant:
Initiate tmt within 72 hrs follow surg: 1
g 2 x dly. Child/adolesc (2-18 yrs): 600
mg/m2 2 x dly, max 2 g dly. Child under
2 yrs: Not recommend. Cardiac/hepatic
transplant: Initiate tmt within 5 days
follow. surgery: 1.5 g 2 x dly. Children:
Not recommend. Elderly (>65 yrs): Ren.
transplant: 1 g 2 x dly; cardiac/hepat.
transplant: 1.5 g 2 x dly. Severe chronic
ren. impair: Max 1 g 2 x dly. Pts to be
carefully observed. No data avail. for
card./hepat. transplant in severe
chron. ren. impair. Severe hepat.
impair: See lit. Tmt during reject.
episodes: Dos. reduct/interrupt. not
reqd. See lit.
Proph. organ reject. in pts. receiv.
allogen. ren. and card. and hepat.
transplants.